ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Allorecognition"

  • 2020 American Transplant Congress

    Evaluating Preformed Donor HLA Reactive T Cells Using PIRCHE-II Algorithm

    T. Tomosugi1, K. Iwasaki2, S. Sakamoto1, A. Kanda1, K. Futamura1, M. Okada1, T. Hiramitsu1, N. Goto1, S. Narumi1, Y. Watarai1, T. Kobayashi2, M. Niemann3, E. Spierings4

    1Transplant and Endocrine Surgery, Nagoya Daini Red Cross Hospital, Nagoya, Aichi, Japan, 2Kidney Transplant Surgery, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan, 3PIRCHE AG, Berlin, Germany, 4University Medical Center Utrecht, Utrecht, Netherlands

    *Purpose: De novo donor-specific HLA antibodies (dnDSA) production involves the indirect allorecognition pathway in which recipient CD4+T cells recognize donor-HLA-derived peptide and recipient HLA class…
  • 2020 American Transplant Congress

    Stability of Immune Phenotype, Alloreactive, and Antiviral Immunity after Switch to Belatacept-Based Regimen after Kidney Transplantation

    J. Schaenman, M. Rossetti, H. Wilhalme, V. Groysberg, G. Sunga, J. Gadzhyan, B. Abdalla, E. Lum, P. Pham, G. Danovitch, J. Veale, H. A. Gritsch, D. Elashoff, E. Reed, S. Bunnapradist

    David Geffen School of Medicine at UCLA, Los Angeles, CA

    *Purpose: This investigator-initiated study examines the impact of belatacept on T cell immune phenotype and function.*Methods: 19 patients with evidence of calcineurin inhibitor (CNI) toxicity…
  • 2020 American Transplant Congress

    Impact of Kidney Transplant Type and Previous Transplant on Baseline Donor-Derived Cell Free DNA

    K. K. Sureshkumar, B. Chopra

    Nephrology and Hypertension, Allegheny General Hospital, Pittsburgh, PA

    *Purpose: Donor derived-cell free DNA (dd-cfDNA) is a biomarker useful in predicting acute rejection in renal allografts. The technology uses next generation sequencing and does…
  • 2019 American Transplant Congress

    SIRPα Typing as a Potential Tool for Risk Stratification in Kidney Transplantation

    A. Casillas-Abundis, A. Tambur, D. F. Pinelli, R. Hod-Dvorai, C. Garcia-Sanchez

    Transplant Immunology Laboratory, Northwestern University, Chicago, IL

    *Purpose: To determine if mismatches in the SIRPα receptor, associated with initiate innate alloresponses in animal models, may impact human kidney transplantation outcome.*Methods: To avoid…
  • 2019 American Transplant Congress

    MDSCs Prolong Allogeneic Cardiac Graft Survival by Regulating Interferon Type 1 Signaling

    S. Cai1, P. T. Sage1, T. J. Borges1, T. Ichimura1, S. K. Eskandari1, J. Y. Choi1, I. Salkuj1, B. S. AI Dulaijan1, H. Allos1, J. Miao2, L. V. Riella1, A. K. Chandraker1, J. R. Azzi1

    1Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 2Boston Children's Hospital, Harvard Medical School, Boston, MA

    *Purpose: We previously demonstrated that donor-derived regulatory dendritic cells (DCreg), contrary to recipient derived DCreg, promote antigen-specific allograft protection. As myeloid-derived suppressor cells (MDSC) show…
  • 2019 American Transplant Congress

    The Impact of Biological Behavior of Allograft Infiltrating Lymphocytes during Early Phase

    Y. Ganchiku, R. Goto, R. Igarashi, R. Kanazawa, K. Shibuya, Y. Fukasaku, N. Kawamura, M. Zaistu, M. Watanabe, M. Fukai, A. Taketomi

    Gastroenterological Surgery I, Hokkaido University, Sapporo, Japan

    *Purpose: The graft infiltrating lymphocytes (GILs) build an immunological microenvironment locally. Reportedly the GILs within 72hrs posttransplantation do not attack allograft, but may prevent from…
  • 2019 American Transplant Congress

    IL-1β and IL-6 Facilitate T Cell Reconstitution in Heart Allograft Recipients Treated with Anti-Thymocyte Globulin

    S. Hasgur, R. Fan, A. Valujskikh

    Inflammation and Immunity, Cleveland Clinic, Cleveland, OH

    *Purpose: Antibody-mediated lymphocyte depletion is used in solid organ and stem cell transplantation. However, T cell reconstitution after lymphoablation may lead to acute rejection and…
  • 2019 American Transplant Congress

    Withaferin A Shifts Circulating Lymphocytes toward Protective T Cell Subsets and Prolongs Islet Allograft Survival in a Mouse Transplant Model

    K. Kumano1, M. Kanak2, C. Darden3, S. Vasu1, Y. Liu4, M. C. Lawrence1, B. Naziruddin4

    1Baylor Scott and White Research Institute, Dallas, TX, 2Department of Surgery, Virginia Commonwealth University, Richmond, VA, 3Institute of Biomedical Studies, Baylor University, Waco, TX, 4Baylor Simmons Transplant Institute, Dallas, TX

    *Purpose: : Immunosuppression protocols improve the efficacy of allogeneic islet transplantation. However, decline in islet graft function and toxicities imposed by current immunosuppressant drugs remain…
  • 2019 American Transplant Congress

    Torque Teno Virus is a Prognostic Biomarker for Acute Biopsy-Proven Alloreactivity in Kidney Transplants

    K. Doberer

    Dpt. of Internal Medicine III, Div. of Nephrology and Dialysis, Medical University of Vienna, Vienna, Austria

    *Purpose: Drug-induced immunosuppression in kidney transplantation is crucial to prevent allograft rejection, but increases risk for infectious, cardiovascular and malignant disease. Tailoring of immunosuppressive drug…
  • 2019 American Transplant Congress

    Blockade of C3aR1 Signaling Suppresses Alloreactive CD8+ T Cell Immunity and Prolongs Murine Cardiac Allograft Survival

    J. Horwitz, D. Mathern, P. Heeger

    Icahn School of Medicine at Mount Sinai, NY, NY

    *Purpose: Activation, differentiation and expansion of alloreactive CD8+ T cells, the dominant effectors that mediate murine heart allograft rejection, requires allorecognition, costimulation, and cytokine-initiated signals.…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 16
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences